Wuhan Shuokang Biological Technology Co.，Ltd(expird)
Free supplier Enterprise Certification
- Free
supplier - 4th
years
Free supplier Enterprise Certification
Business Type:Trading Company
Product Certification&
Enterprise Certification
Country: 
China (Mainland)
Business Type:Trading Company
CAS NO.30123-17-2
100%(1-1000)Metric Ton
Wuhan Shuokang Biological Technology Co.,Ltd
A scientific and technological company integrating product research and development, manufacturing and trading of chemical intermediates, specialized in organic intermediates and pharmaceutical
intermediates. Our company is located in Building B, Headquarters, Han Street, Wuhan, Hubei, CHN. And the main factory is in Hebei, northern China , so we can offer thousands of chemicals with best price. Our products are exported to more than 60 countries overseas, 80% of which are exported to Europe and America, and 20% to Southeast Asia, the Middle East, South Africa and other regions.
Because of excellent quality and after-sales service, our company has gained a good reputation at home and abroad. Sincerely looking forward to establish long-term and mutual beneficial business relationship with worldwide customers.
| Tianeptine sodium salt is a tricyclic antidepressant with an antidepressant mechanism that differs from traditional tricyclic antidepressants in that it increases the reuptake of 5-HT in the synaptic gap and may have the effect of enhancing 5-HT neuronal transmission. It has no affinity for cholinergic or adrenergic receptors. Antidepressant efficacy is similar to tricyclics, but tolerability is better than tricyclics. In animal experiments, it can increase the spontaneous activity of pyramidal cells in hippocampal sites and accelerate the recovery of their functions after inhibition; Chemicalbook can increase the reuptake of 5-hydroxytryptamine by neurons in the cerebral cortex and hippocampal sites. Tianeptine sodium is rapidly and completely absorbed in the digestive tract. Distribution is rapid, with a PPB of 94%. It is completely metabolized in the liver by β-oxidation and N-demethylation, with a short terminal T1/2 clearance of 2.5 h. Very little of the drug in its original form (8%) is excreted from the kidneys, mainly its metabolites from the urine. Clearance T1/2 is prolonged by 1h in patients with renal insufficiency. |